Literature DB >> 27855150

A novel missense mutation in the transcription factor FOXF1 cosegregating with infantile hypertrophic pyloric stenosis in the extended pedigree linked to IHPS5 on chromosome 16q24.

Kate V Everett1, Paris Ataliotis1, Barry A Chioza2, Charles Shaw-Smith3, Eddie M K Chung4.   

Abstract

BACKGROUND: The aim was to identify susceptibility alleles for infantile hypertrophic pyloric stenosis (IHPS) in a pedigree previously linked to IHPS5 on chromosome 16q24.
METHODS: We screened the positional and functional candidate gene FOXF1 by Sanger sequencing in a single affected individual. All family members for whom DNA was available were genotyped to determine cosegregation status of the putative causal variant. Immunofluorescence studies were performed to compare the cellular localization of wildtype and mutant form of the protein. Transcriptional activity was compared using a luciferase assay.
RESULTS: A single novel substitution in FOXF1 (c.416G>A) predicted to result in a missense mutation (R139Q) was shown to cosegregate with disease trait. It was not seen in 560 control chromosomes nor has it been reported in ExAC or ESP. The R139Q substitution affects a conserved arginine residue within the DNA-binding domain of FOXF1. The transcriptional activity of the mutant FOXF1 protein is significantly reduced in comparison to wild-type.
CONCLUSION: These results provide strong evidence that the R139Q substitution in FOXF1 causes IHPS in this family and imply a novel pathological pathway for the condition. They further support a role for FOXF1 in the regulation of embryonic and neonatal development of the gastro-intestinal tract.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27855150     DOI: 10.1038/pr.2016.244

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  45 in total

1.  A NEWLY RECOGNIZED SYNDROME OF MULTIPLE CONGENITAL ANOMALIES.

Authors:  D W SMITH; L LEMLI; J M OPITZ
Journal:  J Pediatr       Date:  1964-02       Impact factor: 4.406

2.  Common variants near MBNL1 and NKX2-5 are associated with infantile hypertrophic pyloric stenosis.

Authors:  Bjarke Feenstra; Frank Geller; Camilla Krogh; Mads V Hollegaard; Sanne Gørtz; Heather A Boyd; Jeffrey C Murray; David M Hougaard; Mads Melbye
Journal:  Nat Genet       Date:  2012-02-05       Impact factor: 38.330

Review 3.  Forkhead transcription factors: key players in development and metabolism.

Authors:  Peter Carlsson; Margit Mahlapuu
Journal:  Dev Biol       Date:  2002-10-01       Impact factor: 3.582

4.  Genome-wide high-density SNP-based linkage analysis of infantile hypertrophic pyloric stenosis identifies loci on chromosomes 11q14-q22 and Xq23.

Authors:  Kate V Everett; Barry A Chioza; Christina Georgoula; Ashley Reece; Francesca Capon; Keith A Parker; Cathy Cord-Udy; Paul McKeigue; Sally Mitton; Agostino Pierro; Prem Puri; Hannah M Mitchison; Eddie M K Chung; R Mark Gardiner
Journal:  Am J Hum Genet       Date:  2008-02-28       Impact factor: 11.025

5.  Decline in infantile hypertrophic pyloric stenosis in Germany in 2000-2008.

Authors:  Jan de Laffolie; Salmai Turial; Matthias Heckmann; Klaus-Peter Zimmer; Felix Schier
Journal:  Pediatrics       Date:  2012-03-19       Impact factor: 7.124

6.  de Lange syndrome: a clinical review of 310 individuals.

Authors:  L Jackson; A D Kline; M A Barr; S Koch
Journal:  Am J Med Genet       Date:  1993-11-15

7.  Parallel incidences of sudden infant death syndrome and infantile hypertrophic pyloric stenosis: a common cause?

Authors:  S Persson; A Ekbom; F Granath; A Nordenskjöld
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

8.  Safety of macrolides during pregnancy.

Authors:  Kueiyu Joshua Lin; Allen A Mitchell; Wai-Ping Yau; Carol Louik; Sonia Hernández-Díaz
Journal:  Am J Obstet Gynecol       Date:  2012-12-16       Impact factor: 8.661

9.  Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides.

Authors:  Henrik Toft Sørensen; Mette Vinther Skriver; Lars Pedersen; Helle Larsen; Finn Ebbesen; Henrik C Schønheyder
Journal:  Scand J Infect Dis       Date:  2003

10.  Plasma lipids, genetic variants near APOA1, and the risk of infantile hypertrophic pyloric stenosis.

Authors:  Bjarke Feenstra; Frank Geller; Lisbeth Carstensen; Paul A Romitti; Izabella Baranowska Körberg; Bruce Bedell; Camilla Krogh; Ruzong Fan; Anna Svenningsson; Michele Caggana; Agneta Nordenskjöld; James L Mills; Jeffrey C Murray; Mads Melbye
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

View more
  4 in total

Review 1.  Clinical, Histopathological, and Molecular Diagnostics in Lethal Lung Developmental Disorders.

Authors:  Marie Vincent; Justyna A Karolak; Gail Deutsch; Tomasz Gambin; Edwina Popek; Bertrand Isidor; Przemyslaw Szafranski; Cedric Le Caignec; Paweł Stankiewicz
Journal:  Am J Respir Crit Care Med       Date:  2019-11-01       Impact factor: 21.405

Review 2.  Pyloric stenosis: an enigma more than a century after the first successful treatment.

Authors:  Yousef El-Gohary; Abdelhafeez Abdelhafeez; Elizabeth Paton; Ankush Gosain; Andrew J Murphy
Journal:  Pediatr Surg Int       Date:  2017-10-13       Impact factor: 1.827

3.  Highly Sensitive Blocker Displacement Amplification and Droplet Digital PCR Reveal Low-Level Parental FOXF1 Somatic Mosaicism in Families with Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins.

Authors:  Justyna A Karolak; Qian Liu; Nina G Xie; Lucia R Wu; Gustavo Rocha; Susana Fernandes; Luk Ho-Ming; Ivan F Lo; David Mowat; Elizabeth K Fiorino; Morris Edelman; Joyce Fox; Denise A Hayes; David Witte; Ashley Parrott; Edwina Popek; Przemyslaw Szafranski; David Y Zhang; Pawel Stankiewicz
Journal:  J Mol Diagn       Date:  2020-02-07       Impact factor: 5.568

4.  A recurrent 8 bp frameshifting indel in FOXF1 defines a novel mutation hotspot associated with alveolar capillary dysplasia with misalignment of pulmonary veins.

Authors:  Justyna A Karolak; Albino Bacolla; Qian Liu; Patrick E Lantz; John Petty; Pamela Trapane; Karin Panzer; Balagangadhar R Totapally; Zhiyv Niu; Rui Xiao; Nina G Xie; Lucia R Wu; Przemyslaw Szafranski; David Y Zhang; Paweł Stankiewicz
Journal:  Am J Med Genet A       Date:  2019-08-22       Impact factor: 2.802

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.